Evidence map›Paper›PMID 41367045›Full record

ArticleNature2026

Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders.

Serena Tamura, Andrew D Nelson, Perry W E Spratt, Elizabeth C Hamada, Xujia Zhou, Henry Kyoung, Zizheng Li, Coline Arnould, Vladyslav Barskyi, Beniamin Krupkin and 18 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Serena Tamura *Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Andrew D Nelson *Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Perry W E Spratt *Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Elizabeth C HamadaWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0009-0008-0614-8141
Xujia ZhouDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Henry KyoungWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Zizheng LiDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Coline ArnouldDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Vladyslav BarskyiDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Beniamin KrupkinDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7457-7342
Kiana YoungDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Jingjing ZhaoDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Stephanie S HoldenDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Atehsa SahagunWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-7521-3279
Caroline M KeeshenWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Congyi LuStanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Roy Ben-ShalomWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Sunrae E TalomaWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7210-8614
Selin SchamilogluWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Ying C LiWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0009-0009-4792-8336
Lia MinDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-3977-1684
Paul M JenkinsDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-4207-5823
Jen Q PanStanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Jeanne T PazDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6339-8130
Stephan J SandersWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9112-5148
Navneet MatharuDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Nadav AhituvDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. nadav.ahituv@ucsf.edu.ORCID http://orcid.org/0000-0002-7434-8144
Kevin J BenderWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. kevin.bender@ucsf.edu.ORCID http://orcid.org/0000-0001-7084-1532

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41367045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.